Wealth Enhancement Advisory Services
IMNM icon

Wealth Enhancement Advisory Services’s Immunome IMNM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,660
Closed -$244K – 3724
2025
Q3 		$244K Sell
17,660
-35,527
-67% -$353K ﹤0.01% 2957
2025
Q2 		$470K Buy
53,187
+1,643
+3% +$13.5K ﹤0.01% 2271
2025
Q1 		$347K Buy
51,544
+10,039
+24% +$96.3K ﹤0.01% 2328
2024
Q4 		$441K Buy
41,505
+2,005
+5% +$24.2K ﹤0.01% 2081
2024
Q3 		$577K Sell
39,500
-2,070
-5% -$29.4K ﹤0.01% 1732
2024
Q2 		$503K Buy
41,570
+30,617
+280% +$479K ﹤0.01% 1650
2024
Q1 		$270K Sell
10,953
-2,047
-16% -$41.5K ﹤0.01% 1988
2023
Q4 		$139K Buy
+13,000
New +$108K ﹤0.01% 2140

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wealth Enhancement Advisory Services's IMNM Position: Q4 2025 in Review

Wealth Enhancement Advisory Services sold out of Immunome (IMNM) in Q4 2025, closing a stake of 17,660 shares — an estimated $244K sold.

Wealth Enhancement Advisory Services first reported a position in IMNM in Q4 2023 and held it in 8 quarters. The position peaked at $577K in Q3 2024. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • Wealth Enhancement Advisory Services reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 17,660 Immunome shares in Q4 2025, an estimated $244K.
  • Wealth Enhancement Advisory Services first reported a position in Immunome in Q4 2023 and held it in 8 quarters.
  • Wealth Enhancement Advisory Services's Immunome position peaked at $577K in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.